[HTML][HTML] Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study
…, J Nielsen, CH Hansen, MA Andersen… - PLoS …, 2022 - journals.plos.org
Background Individuals with a prior Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection have a moderate to high degree of protection against reinfection, …
infection have a moderate to high degree of protection against reinfection, …
Real‐world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib
…, T Nielsen, I Christiansen, MA Andersen… - European journal of …, 2020 - Wiley Online Library
Ibrutinib has now been approved for treatment of chronic lymphocytic leukemia (CLL) in both
front‐line setting and as later‐line treatment. However, knowledge about the outcomes and …
front‐line setting and as later‐line treatment. However, knowledge about the outcomes and …
[HTML][HTML] And predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study
MA Andersen, CT Eriksen, C Brieghel, JL Biccler… - …, 2018 - ncbi.nlm.nih.gov
With the international prognostic index for patients with chronic lymphocytic leukemia (CLL-IPI),
we have a tool to identify patients with a high risk of progression. 1, 2 Despite improved …
we have a tool to identify patients with a high risk of progression. 1, 2 Despite improved …
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death
Hypogammaglobulinemia is the most common immune deficiency in chronic lymphocytic
leukemia (CLL). However, the prognostic significance in terms of morbidity and mortality …
leukemia (CLL). However, the prognostic significance in terms of morbidity and mortality …
Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study
Patients with chronic lymphocytic leukemia (CLL) have a high risk of bloodstream infections
(BSI). BSI cause significant morbidity and mortality among CLL patients; approximately one-…
(BSI). BSI cause significant morbidity and mortality among CLL patients; approximately one-…
Differences and temporal changes in risk of invasive pneumococcal disease in adults with hematological malignancies: results from a nationwide 16-year cohort study
MA Andersen, CU Niemann… - Clinical Infectious …, 2021 - academic.oup.com
Background Patients with hematological malignancies (HM) are known to carry an increased
risk of invasive pneumococcal disease (IPD). However, temporal variations in IPD risks …
risk of invasive pneumococcal disease (IPD). However, temporal variations in IPD risks …
[HTML][HTML] Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
Background The immune pathogenesis underlying the diverse clinical course of COVID-19
is poorly understood. Currently, there is an unmet need in daily clinical practice for early …
is poorly understood. Currently, there is an unmet need in daily clinical practice for early …
Real‐world outcomes upon second‐line treatment in patients with chronic lymphocytic leukaemia
N Vainer, K Aarup, MA Andersen… - British Journal of …, 2023 - Wiley Online Library
For chronic lymphocytic leukaemia (CLL), targeted drugs have become the standard of care,
in particular for second‐line treatment. In this study, overall survival (OS), treatment‐free …
in particular for second‐line treatment. In this study, overall survival (OS), treatment‐free …
Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study
Chronic lymphocytic leukemia (CLL) is accompanied by increased risk of potentially fatal
infections. While this can mostly be attributed to disease-related immune dysfunction, it is not …
infections. While this can mostly be attributed to disease-related immune dysfunction, it is not …
Twenty-five years of triptans–a nationwide population study
Background The efficacy of triptans as the main acute treatment strategy for migraine
headache at the population-wide level needs to be understood to inform clinical decision-making. …
headache at the population-wide level needs to be understood to inform clinical decision-making. …